Selected research
Industry Research
Piroxicam API Industry Research Report 2026
Market perspective
The global Piroxicam API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Piroxicam API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Piroxicam API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Piroxicam API include Nostrum, SK Chemicals, Pidi Pharmaceutical, Pfizer, Jumpcan Pharmaceutical, Jiangxi Pharmaceutical, Mylan, Maoxiang Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Piroxicam API market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Piroxicam API Market by Company
Nostrum
SK Chemicals
Pidi Pharmaceutical
Pfizer
Jumpcan Pharmaceutical
Jiangxi Pharmaceutical
Mylan
Maoxiang Pharmaceutical
Teva
Viwit Pharmaceutical
XinAn Pharmaceutical
Changjiang Pharmaceutical
Piroxicam API Segment by Type
Purity≥ 99%
Purity≥ 99.5%
Piroxicam API Segment by Application
Injection
Ointment
Tablets
Capsule
Piroxicam API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piroxicam API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Piroxicam API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Piroxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥ 99%
- Purity≥ 99.5%
Applications
- Injection
- Ointment
- Tablets
- Capsule
Companies covered
- Nostrum
- SK Chemicals
- Pidi Pharmaceutical
- Pfizer
- Jumpcan Pharmaceutical
- Jiangxi Pharmaceutical
- Mylan
- Maoxiang Pharmaceutical
- Teva
- Viwit Pharmaceutical
- XinAn Pharmaceutical
- Changjiang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Piroxicam API Market Size (2021-2032)
- 2.2.2 Global Piroxicam API Sales (2021-2032)
- 2.2.3 Global Piroxicam API Market Average Price (2021-2032)
- 2.3 Piroxicam API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥ 99%
- 2.3.3 Purity≥ 99.5%
- 2.4 Piroxicam API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Ointment
- 2.4.4 Tablets
- 2.4.5 Capsule
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Piroxicam API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Piroxicam API Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Piroxicam API Revenue of Manufacturers (2021-2026)
- 3.4 Global Piroxicam API Average Price by Manufacturers (2021-2026)
- 3.5 Global Piroxicam API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Piroxicam API, Product Type & Application
- 3.8 Global Manufacturers of Piroxicam API, Established Date
- 3.9 Global Piroxicam API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Nostrum
- 4.1.1 Nostrum Company Information
- 4.1.2 Nostrum Business Overview
- 4.1.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Nostrum Piroxicam API Product Portfolio
- 4.1.5 Nostrum Recent Developments
- 4.2 SK Chemicals
- 4.2.1 SK Chemicals Company Information
- 4.2.2 SK Chemicals Business Overview
- 4.2.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SK Chemicals Piroxicam API Product Portfolio
- 4.2.5 SK Chemicals Recent Developments
- 4.3 Pidi Pharmaceutical
- 4.3.1 Pidi Pharmaceutical Company Information
- 4.3.2 Pidi Pharmaceutical Business Overview
- 4.3.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
- 4.3.5 Pidi Pharmaceutical Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Piroxicam API Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Jumpcan Pharmaceutical
- 4.5.1 Jumpcan Pharmaceutical Company Information
- 4.5.2 Jumpcan Pharmaceutical Business Overview
- 4.5.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
- 4.5.5 Jumpcan Pharmaceutical Recent Developments
- 4.6 Jiangxi Pharmaceutical
- 4.6.1 Jiangxi Pharmaceutical Company Information
- 4.6.2 Jiangxi Pharmaceutical Business Overview
- 4.6.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
- 4.6.5 Jiangxi Pharmaceutical Recent Developments
- 4.7 Mylan
- 4.7.1 Mylan Company Information
- 4.7.2 Mylan Business Overview
- 4.7.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mylan Piroxicam API Product Portfolio
- 4.7.5 Mylan Recent Developments
- 4.8 Maoxiang Pharmaceutical
- 4.8.1 Maoxiang Pharmaceutical Company Information
- 4.8.2 Maoxiang Pharmaceutical Business Overview
- 4.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
- 4.8.5 Maoxiang Pharmaceutical Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Piroxicam API Product Portfolio
- 4.9.5 Teva Recent Developments
- 4.10 Viwit Pharmaceutical
- 4.10.1 Viwit Pharmaceutical Company Information
- 4.10.2 Viwit Pharmaceutical Business Overview
- 4.10.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
- 4.10.5 Viwit Pharmaceutical Recent Developments
- 4.11 XinAn Pharmaceutical
- 4.11.1 XinAn Pharmaceutical Company Information
- 4.11.2 XinAn Pharmaceutical Business Overview
- 4.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
- 4.11.5 XinAn Pharmaceutical Recent Developments
- 4.12 Changjiang Pharmaceutical
- 4.12.1 Changjiang Pharmaceutical Company Information
- 4.12.2 Changjiang Pharmaceutical Business Overview
- 4.12.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
- 4.12.5 Changjiang Pharmaceutical Recent Developments
5 Global Piroxicam API Market Scenario by Region
- 5.1 Global Piroxicam API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Piroxicam API Sales by Region: 2021-2032
- 5.2.1 Global Piroxicam API Sales by Region: 2021-2026
- 5.2.2 Global Piroxicam API Sales by Region: 2027-2032
- 5.3 Global Piroxicam API Revenue by Region: 2021-2032
- 5.3.1 Global Piroxicam API Revenue by Region: 2021-2026
- 5.3.2 Global Piroxicam API Revenue by Region: 2027-2032
- 5.4 North America Piroxicam API Market Facts & Figures by Country
- 5.4.1 North America Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Piroxicam API Sales by Country (2021-2032)
- 5.4.3 North America Piroxicam API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Piroxicam API Market Facts & Figures by Country
- 5.5.1 Europe Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Piroxicam API Sales by Country (2021-2032)
- 5.5.3 Europe Piroxicam API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Piroxicam API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Piroxicam API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Piroxicam API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Piroxicam API Market Facts & Figures by Country
- 5.7.1 South America Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Piroxicam API Sales by Country (2021-2032)
- 5.7.3 South America Piroxicam API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Piroxicam API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Piroxicam API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Piroxicam API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Piroxicam API Sales by Type (2021-2032)
- 6.1.1 Global Piroxicam API Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Piroxicam API Sales Market Share by Type (2021-2032)
- 6.2 Global Piroxicam API Revenue by Type (2021-2032)
- 6.2.1 Global Piroxicam API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Piroxicam API Revenue Market Share by Type (2021-2032)
- 6.3 Global Piroxicam API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Piroxicam API Sales by Application (2021-2032)
- 7.1.1 Global Piroxicam API Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Piroxicam API Sales Market Share by Application (2021-2032)
- 7.2 Global Piroxicam API Revenue by Application (2021-2032)
- 7.2.1 Global Piroxicam API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Piroxicam API Revenue Market Share by Application (2021-2032)
- 7.3 Global Piroxicam API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Piroxicam API Value Chain Analysis
- 8.1.1 Piroxicam API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Piroxicam API Production Mode & Process
- 8.2 Piroxicam API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Piroxicam API Distributors
- 8.2.3 Piroxicam API Customers
9 Global Piroxicam API Analyzing Market Dynamics
- 9.1 Piroxicam API Industry Trends
- 9.2 Piroxicam API Industry Drivers
- 9.3 Piroxicam API Industry Opportunities and Challenges
- 9.4 Piroxicam API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst